Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
behcet syndrome
MeSH D001528 - behcet syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D017445:
Vascular skin diseases
0 Companies
0 Drugs
Success rate
D014606:
Anterior uveitis
1 Company
1 Drug
$
Success rate
D014657:
Vasculitis
8 Companies
1 Drug
$
Success rate
D056660:
Hereditary autoinflammatory diseases
0 Companies
0 Drugs
Success rate
D009059:
Mouth diseases
78 Companies
13 Drugs
$
Success rate
D001528:
Behcet syndrome
3 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
33
%
1/3
Phase 2
10
%
1/10
Phase 3
11
%
1/9
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bristol Myers Squibb
Thalidomide
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use